2 years ago
RARE
AnalystsSalveen RichterSalveen Richter's Stock Forecasts
AnalystsSalveen Richter
Analyst Ranking
Top 21%
#1052 out of 5154 analysts
Average Return
+6.05%
Win Rate
39%41 out of 106
Risk vs Reward
Poor
Good
Salveen Richter's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Intellia Therapeutics IncNTLA | +569.03% | $23.51 | $157.29 | 2020-09-18 - 2021-09-17 | Strong Buy |
4d Molecular Therapeutics IncFDMT | +274.03% | $3.08 | $11.52 | 2025-05-09 - 2025-12-16 | Strong Buy |
Relay Therapeutics IncRLAY | +160.92% | $3.25 | $8.48 | 2025-02-27 - 2025-12-16 | Strong Buy |
Passage Bio IncPASG | +150.07% | $280.40 | $701.20 | 2020-03-24 - 2020-06-25 | Strong Buy |
Denali Therapeutics IncDNLI | +149.21% | $27.98 | $69.73 | 2020-01-27 - 2021-01-27 | Strong Buy |
Salveen Richter Analyst Color
Get additional color on Salveen Richter's coverage of popular stocks
2 years ago
SAGE
3 years ago
ALLO
Salveen Richter's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Agios Pharmaceuticals IncAGIO | 6 | Hold | $25.00 | -4.18% | Maintains | a month ago |
Amicus Therapeutics IncFOLD | 3 | Hold | $11.00 | +1.01% | Maintains | a month ago |
Uniqure NvQURE | 9 | Hold | $38.00 | +73.60% | Maintains | a month ago |
Arcus Biosciences IncRCUS | 4 | Hold | $16.00 | -27.93% | Maintains | 2 months ago |
Ionis Pharmaceuticals IncIONS | 5 | Hold | $65.00 | -17.06% | Upgrades | 3 months ago |
Apellis Pharmaceuticals IncAPLS | 9 | Strong Sell | $18.00 | -28.88% | Downgrades | 3 months ago |
Immunome IncIMNM | 1 | Strong Buy | $26.00 | +10.73% | Initiates Coverage On | 3 months ago |
Alnylam Pharmaceuticals IncALNY | 6 | Strong Buy | $566.00 | +44.69% | Maintains | 3 months ago |
4d Molecular Therapeutics IncFDMT | 5 | Strong Buy | $38.00 | +229.86% | Maintains | 4 months ago |
Sarepta Therapeutics IncSRPT | 6 | Hold | $19.00 | -14.84% | Maintains | 4 months ago |
Acadia Pharmaceuticals IncACAD | 7 | Strong Sell | $17.00 | -36.57% | Maintains | 4 months ago |
Enliven Therapeutics IncELVN | 1 | Strong Buy | $37.00 | +118.81% | Initiates Coverage On | 6 months ago |
Crispr Therapeutics AgCRSP | 4 | Hold | $47.00 | -16.03% | Maintains | 7 months ago |
Biomarin Pharmaceutical IncBMRN | 1 | Strong Buy | $104.00 | +100.89% | Maintains | 7 months ago |
Summit Therapeutics IncSMMT | 2 | Strong Buy | $41.00 | +137.96% | Maintains | 8 months ago |
Adaptive Biotechnologies CorpADPT | 5 | Strong Buy | $10.00 | -37.23% | Maintains | 8 months ago |
Regeneron Pharmaceuticals IncREGN | 4 | Strong Buy | $804.00 | +7.72% | Maintains | 8 months ago |
Biogen IncBIIB | 4 | Strong Buy | $197.00 | +14.87% | Maintains | 8 months ago |
Relay Therapeutics IncRLAY | 3 | Strong Buy | $18.00 | +112.26% | Maintains | 10 months ago |
Gilead Sciences IncGILD | 4 | Hold | $96.00 | -19.18% | Maintains | 10 months ago |
Moderna IncMRNA | 9 | Hold | $51.00 | +70.63% | Downgrades | a year ago |
Denali Therapeutics IncDNLI | 4 | Strong Buy | $40.00 | +135.02% | Maintains | a year ago |
Intellia Therapeutics IncNTLA | 6 | Hold | $12.00 | +31.58% | Maintains | a year ago |
Incyte CorpINCY | 5 | Hold | $70.00 | N/A | Maintains | a year ago |
Ultragenyx Pharmaceutical IncRARE | 3 | Strong Buy | $76.00 | N/A | Maintains | a year ago |
Sage Therapeutics IncSAGE | 6 | Hold | $11.00 | N/A | Maintains | a year ago |
Amgen IncAMGN | 3 | Strong Buy | $350.00 | N/A | Maintains | 2 years ago |
Vertex Pharmaceuticals IncVRTX | 4 | Strong Buy | $559.00 | N/A | Maintains | 2 years ago |
2seventy Bio IncTSVT | 4 | Hold | $5.00 | N/A | Downgrades | 2 years ago |
Centessa Pharmaceuticals PLCCNTA | 4 | Hold | $5.00 | N/A | Maintains | 2 years ago |
Allogene Therapeutics IncALLO | 4 | Strong Buy | $31.00 | N/A | Maintains | 3 years ago |
Autodesk IncADSK | 1 | Strong Buy | $225.00 | N/A | Maintains | 3 years ago |
Prime Medicine IncPRME | 1 | Hold | $22.00 | N/A | Initiates Coverage On | 3 years ago |
Lyell Immunopharma IncLYEL | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Precision Biosciences IncDTIL | 5 | Hold | $30.00 | N/A | Maintains | 3 years ago |
Kronos Bio IncKRON | 2 | Strong Buy | $14.00 | N/A | Maintains | 3 years ago |
Recursion Pharmaceuticals IncRXRX | 3 | Hold | $9.00 | N/A | Maintains | 3 years ago |
Taysha Gene Therapies IncTSHA | 2 | Hold | $3.00 | N/A | Downgrades | 3 years ago |
Sana Biotechnology IncSANA | 2 | Hold | $6.00 | N/A | Maintains | 3 years ago |
Bread Financial Holdings IncBFH | 1 | Hold | $43.00 | N/A | Maintains | 3 years ago |
Bluebird Bio IncBLUE | 6 | Strong Sell | $60.00 | N/A | Maintains | 3 years ago |
Atara Biotherapeutics IncATRA | 1 | Strong Sell | $100.00 | N/A | Maintains | 4 years ago |
Reata Pharmaceuticals IncRETA | 2 | Hold | $39.00 | N/A | Downgrades | 4 years ago |
Omega Therapeutics IncOMGAQ | 1 | Hold | $22.00 | N/A | Initiates Coverage On | 4 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Strong Sell | $10.00 | N/A | Downgrades | 4 years ago |
Tcr2 Therapeutics IncTCRR | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Passage Bio IncPASG | 3 | Strong Buy | $600.00 | N/A | Upgrades | 5 years ago |
Mirati Therapeutics IncMRTX | 1 | Strong Buy | $151.00 | N/A | Initiates Coverage On | 6 years ago |
Paccar IncPCAR | 3 | Hold | $50.00 | N/A | Maintains | 6 years ago |
Arrowhead Pharmaceuticals IncARWR | 1 | Hold | $45.00 | N/A | Initiates Coverage On | 6 years ago |
Cellectis SaCLLS | 1 | Strong Sell | $11.00 | N/A | Downgrades | 6 years ago |
Seagen IncSGEN | 1 | Strong Buy | $165.00 | N/A | Maintains | 6 years ago |
Acorda Therapeutics IncACORQ | 4 | Strong Sell | $1,200.00 | N/A | Downgrades | 7 years ago |
Gw Pharmaceuticals PLCGWPH | 1 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Spark Therapeutics IncONCE | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.